论文信息 - Linezolid treatment of prosthetic hip infections due to methicillin-resistant Staphylococcus aureus (MRSA) - 字舞流文

Linezolid treatment of prosthetic hip infections due to methicillin-resistant Staphylococcus aureus (MRSA)

M. Bassetti | L. Molfetta | G. Cenderello | A. di Biagio | V. del Bono | D. Bassetti | F. Pipino | A. Palermo

[1] J. C. Maddox,et al. Linezolid and reversible myelosuppression. , 2001, JAMA.

[2] A. Hanssen,et al. Staphylococcus aureus prosthetic joint infection treated with prosthesis removal and delayed reimplantation arthroplasty. , 1999, Mayo Clinic proceedings.

[3] R. Moellering. Introduction: Problems with Antimicrobial Resistance in Gram-Positive Cocci , 1998 .

[4] R. Moellering. Problems with antimicrobial resistance in gram-positive cocci. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5] J. Kilburn,et al. In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents , 1996, Antimicrobial agents and chemotherapy.

[6] M. Liang,et al. Total hip arthroplasty: use and select complications in the US Medicare population. , 1996, American journal of public health.

[7] A. Hanssen,et al. Infection after total hip arthroplasty. Past, present, and future. , 1995, The Journal of bone and joint surgery. American volume.

[8] Eftekhar Ns,et al. Failures and reoperations following low-friction arthroplasty of the hip. A five- to fifteen-year follow-up study. , 1986 .

[9] John E. Bennett,et al. Principles and practice of infectious diseases. Vols 1 and 2. , 1979 .